Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

POLMON

DEXCHLORPHENIRAMINE MALEATE

Standard Dose
2MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview POLMON is listed in Drugs@FDA under application 202520 (ANDA).

Marketing status: Prescription Active ingredient DEXCHLORPHENIRAMINE MALEATE Form and strength SYRUP;ORAL - 2MG/5ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2018-07-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview POLMON is listed in Drugs@FDA under application 202520 (ANDA). Marketing status: Prescription Active ingredient DEXCHLORPHENIRAMINE MALEATE Form and strength SYRUP;ORAL - 2MG/5ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2018-07-16 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.